BRD2 and metabolic dysfunction-associated steatotic liver disease: As showed in Table 4, age, diabetes duration, overweight/obesity, central obesity, hyperuricemia, hypertension, and dyslipidemia did not interact with FSH in relation to NAFLD (p for interaction was .571, .261, .922, .062, .568, .165, .414, respectively).